Radiotheranostics in Oncology: Optimising the Science, Building Capacity and Streamlining the Regulation

Start date

04 Mar 2025

End date

04 Mar 2025

Location

Room “Scene AB”

Starts on

04 Mar 2025 at 13:15 CET

Add to Calendar 04-03-2025 13:15 04-03-2025 14:15 Europe/Paris Radiotheranostics in Oncology: Optimising the Science, Building Capacity and Streamlining the Regulation
More info on: https://www.esmo.org/meeting-calendar/esmo-tat-2025/esmo-colloquia/radiotheranostics-in-oncology-optimising-the-science-building-capacity-and-streamlining-the-regulation Room “Scene AB”

Programme

• 4 March 2025

13:15

Welcome and introduction

Alessandra Gennari, Novara, Italy

13:20

R&D for radioligand therapies in oncology (preclinical): Target discovery, spatial target expression and tumour microenvironment

Bart Cornelissen, Groningen, Netherlands

13:30

Clinical drug development of radiotheranostics: Trial design, administered vs absorbed dose and the role of internal dosimetry

Alessandra Gennari, Novara, Italy

13:40

Capacity building for implementation of RLT in clinical practice (human resources, infrastructure, supply): Quality and upscaling

Anne-Laure Giraudet, Lyon, France

13:50

Current policy and regulatory hurdles for RLT implementation: Regulatory approval, centre accreditation and radioprotection, reimbursement

Valentina Di Iorio, Meldola, Italy

14:00

Q&A and discussion

All speakers

14:10

Concluding remarks

Bart Cornelissen, Groningen, Netherlands

Learning objectives

• To be updated on differentiating features of the preclinical and clinical development of radiotheranostics
• To be provided insights on the requirements related to capacity-building for the implementation of radiotheranostics
• To be informed on policy and regulatory hurdles for the wide-scale application of radiotheranostics